Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.
about
Impaired response inhibition in the rat 5 choice continuous performance task during protracted abstinence from chronic alcohol consumptionDevelopment of a Diverse Learning Experience for Diverse Psychiatry Resident Needs: A Four-Year Biological Psychiatry Curriculum Incorporating Principles of Neurobiology, Psychopharmacology, and Evidence-Based Practice.Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawalActivation and role of the medial prefrontal cortex (mPFC) in extinction of ethanol-induced associative learning in miceGray matter volume correlates of global positive alcohol expectancy in non-dependent adult drinkersPropranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysisThe behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.Pathological gambling and the loss of willpower: a neurocognitive perspective.Naloxone effects on extinction of ethanol- and cocaine-induced conditioned place preference in mice.Risk-preferring rats make worse decisions and show increased incubation of craving after cocaine self-administration.Increased impulsivity in rats as a result of repeated cycles of alcohol intoxication and abstinence.Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala.Dysregulated Glycine Signaling Contributes to Increased Impulsivity during Protracted Alcohol Abstinence.Phosphorylation of calcium/calmodulin-dependent protein kinase II in the rat dorsal medial prefrontal cortex is associated with alcohol-induced cognitive inflexibility.Cocaine use severity and cerebellar gray matter are associated with reversal learning deficits in cocaine-dependent individuals.
P2860
Q27336033-4CA2C60B-C5B7-4A60-8E8C-5C73E4E79A11Q33715038-9828B9C0-C082-4F4F-B290-5DF37B088668Q35589974-B0C6A630-0B2E-41E1-A687-14A07818445AQ35633946-8D406993-B902-46FA-A778-95121E991BABQ36926883-2A1303AA-E230-4976-BB87-CAE9A1CD821CQ36955320-477461A9-61D3-44D4-82A0-3426CC39457BQ37381671-2B48AA32-8BC9-48D3-8104-927E1F3C15E7Q37649475-8037202C-6D54-47D5-AA59-E8158C095BE3Q38707820-904FA275-ED59-4F7D-BD5D-CF33422EF354Q39899437-DBB34BDC-C708-460C-AFEA-AFF5CCC32A99Q40819523-AEC12620-4018-4FCD-91BF-3DDAF663AC44Q41952668-36ED039B-E988-4052-8071-F69A3029D4DAQ42320456-6559B4CC-DA39-44CC-B22B-8FD6A2D0F2AEQ47756221-F8066D74-9320-4779-A384-20960ED6BCADQ50669987-135AEC3D-EDE8-48F0-804A-409FEF9959EB
P2860
Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental medicine in drug ...... nd neurobiological biomarkers.
@en
Experimental medicine in drug ...... nd neurobiological biomarkers.
@nl
type
label
Experimental medicine in drug ...... nd neurobiological biomarkers.
@en
Experimental medicine in drug ...... nd neurobiological biomarkers.
@nl
prefLabel
Experimental medicine in drug ...... nd neurobiological biomarkers.
@en
Experimental medicine in drug ...... nd neurobiological biomarkers.
@nl
P2093
P2860
P356
P1476
Experimental medicine in drug ...... nd neurobiological biomarkers.
@en
P2093
David N Stephens
Hans S Crombag
Theodora Duka
P2860
P304
P356
10.1177/0269881110388324
P407
P577
2010-12-17T00:00:00Z